BWL
ANIP icon

Bogart Wealth LLC’s ANI Pharmaceuticals ANIP Stock Holding History

Bogart Wealth LLC’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83 Hold
1
– – ﹤0.01% 1948
2026
Q1 		$77 Hold
1
– – ﹤0.01% 1750
2025
Q4 		$79 Hold
1
– – ﹤0.01% 1558
2025
Q3 		$92 Hold
1
– – ﹤0.01% 1504
2025
Q2 		$65 Hold
1
– – ﹤0.01% 1430
2025
Q1 		$67 Sell
1
-39
-98% -$2.33K ﹤0.01% 1383
2024
Q4 		$2.21K Buy
+40
New +$2.3K ﹤0.01% 1081

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bogart Wealth LLC's ANIP Position: Q2 2026 in Review

Bogart Wealth LLC held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 1 share worth $83. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Bogart Wealth LLC first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.21K in Q4 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Bogart Wealth LLC held 1 share of ANI Pharmaceuticals worth $83 as of Q2 2026.
  • Bogart Wealth LLC left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1948 holding.
  • Bogart Wealth LLC first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Bogart Wealth LLC's ANI Pharmaceuticals position peaked at $2.21K in Q4 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.